Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2018

Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,681 recalls, newest first.

Class II · Moderate risk

Progesterone 50 mg

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0650-2018
Class II · Moderate risk

Pregnenolone 100 mg

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0649-2018
Class II · Moderate risk

Naltrexone 200 mg pellet

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0648-2018
Class II · Moderate risk

Vitamin D 50

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0646-2018
Class II · Moderate risk

Lipoic Acid 25mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0640-2018
Class II · Moderate risk

HCG 1000 units/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0639-2018
Class II · Moderate risk

Glutathione 200mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0638-2018
Class II · Moderate risk

CoEnzymeQ10 25mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0637-2018
Class II · Moderate risk

Biotin Suspension 10mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0636-2018
Class II · Moderate risk

Ascorbic Acid

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0634-2018
Class III · Low risk

Fabior (tazarotene)

Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.

Terminated Wrong potency / content Mayne Pharma Inc NDC 51862-295-10 D-0616-2018
Class II · Moderate risk

Estradiol Vaginal Inserts

Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

Terminated Packaging defect Teva Pharmaceuticals USA NDC 0093-3223-08 D-0620-2018
Class III · Low risk

Indomethacin Capsules USP

Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual adult dosage of "One capsule 2 or 3 times a day.

Terminated Labeling / mix-up Glenmark Pharmaceuticals Inc., USA NDC 68462-302-01 D-0606-2018

Recalls by year